Feasibility of Temporary Pancreatic Stenting after Early Endoscopic Retrograde Cholangiopancreatography in Patients with Acute Biliary Pancreatitis.
10.4166/kjg.2017.70.5.247
- Author:
Jun Kyu LEE
1
;
Dong Kee JANG
;
Hyun Woo KANG
;
Sang Hyub LEE
Author Information
1. Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
- Publication Type:Original Article
- Keywords:
Acute biliary pancreatitis;
Endoscopic retrograde cholangiopancreatography;
Pancreatic stenting
- MeSH:
Cholangiopancreatography, Endoscopic Retrograde*;
Cholangitis;
Humans;
Mortality;
Necrosis;
Pancreatic Ducts;
Pancreatitis*;
Prospective Studies;
Stents*;
Systemic Inflammatory Response Syndrome
- From:The Korean Journal of Gastroenterology
2017;70(5):247-252
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: To assess the safety and effectiveness of temporary pancreatic stenting after early endoscopic retrograde cholangiopancreatography (ERCP) in patients with acute biliary pancreatitis regardless of the severity or concomitant cholangitis. METHODS: Temporary pancreatic stenting was performed in 79 patients with visualized pancreatic duct during ERCP. The outcomes of 64 patients with adequate pancreatic stenting (PS) and 15 patients with inadequate pancreatic stenting (no PS) were compared in this prospective, observational trial. RESULTS: The baseline characteristics were similar. Development of systemic inflammatory response syndrome (7.8% for PS vs. 13.3% for no PS; p=0.50) and mortality (none for both groups; p=0.99) did not differ. However, fewer local complications occurred in PS than in no PS (4.7% for PS vs. 20.0% for no PS; p=0.04) and the difference was most outstanding in necrosis (1.6% for PS vs. 13.3% for no PS; p=0.03). CONCLUSIONS: Temporary pancreatic stenting after early ERCP should be considered safe, as complications did not increase even in cases of inadequate stenting. However, if successful, there appears to be a reduction in local complications.
